| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―01 |
Effects of Drugs for the Treatment of Multiple Sclerosis in Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Expression of Angiotensin-converting Enzyme 2 in vitro |
Roxana P. Ginerete, Tiziana Imbriglio, Marika Alborghetti, Milena Cannella, Alessia Ceccherelli, Sonia Castaldi, Serena Notartomaso, Laura Norma, Giuseppe Battaglia, Valeria Bruno |
| 2 |
[GO] |
2026―Jan―23 |
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the
COVID-19 Pandemic: Implications for Central Effects |
Maria Antonietta De Luca, Cristina Miliano, Amanda Roxburgh, Myfanwy Graham, Francesca Caria, Amira Guirguis, Fabrizio Schifano, Suzanne Nielsen, Nicola Simola, Giulia Costa |
| 3 |
[GO] |
2025―Jul―23 |
Resilience and Recalibration of Bibliometric Indicators in Neurosciences and Neuropharmacology Journals After COVID-19: A Longitudinal Rate
of Change Analysis Using Mixed-Effects Models |
Camilo Rios-Castañeda, Heriberto Aguirre-Meneses, Marco-Antonio Nuñez-Gaona, Ernesto Roldan-Valadez |
| 4 |
[GO] |
2024―Nov―07 |
Neuropsychiatric Manifestations of COVID-19 Disease and Post Covid Syndrome: The Role of N Acetyl-cysteine and Acetyl-L-carnitine |
Tommaso Barlattani, Giuseppe Celenza, Alessandro Cavatassi, Franco Minutillo, Valentina Socci, Carolina Pinci, Riccardo Santini, Francesca Pacitti |
| 5 |
[GO] |
2023―Oct―09 |
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period |
Wesley Dawison de Lima, Michael Douglas da Silva, Eurico de Souza Costa, Francisco Irochima Pinheiro, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci, José Rodolfo Lopes de Paiva Cavalcanti, Fausto Pierdoná Guzen |
| 6 |
[GO] |
2023―Jul―30 |
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19 |
|
| 7 |
[GO] |
2023―Jun―16 |
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19 |
Cindy Bandala, Eleazar Lara-Padilla, Noemí Cárdenas-Rodríguez, Samuel Reyes-Long, Alfredo Cortés-Algara, Itzel Jatziri Contreras-García, Teresita Rocío Cruz-Hernández, Alfonso Alfaro-Rodriguez, José Luis Cortes-Altamirano, Martín Perez-Santos, Maricruz Anaya-Ruiz |
| 8 |
[GO] |
2022―Dec―07 |
Emerging Evidence for Neuropsycho-Consequences of COVID-19 |
Jingwen Li |
| 9 |
[GO] |
2022―Jul―17 |
Emerging Evidence for Neuropsycho-Consequences of COVID-19 |
Li, JW |
| 10 |
[GO] |
2022―Mar―11 |
Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma |
Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, Emanuela Amici, Giada Trovini, Filippo Perrini, Alessandro Di Giovanni, Valeria Giovanetti, Georgios D. Kotzalidis |
| 11 |
[GO] |
2021―Dec―24 |
Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19 |
George B. Stefano, Pascal Büttiker, Simon Weissenberger, Radek Ptacek, Fuzhou Wang, Tobias Esch, Thomas V. Bilfinger, Richard M. Kream |
| 12 |
[GO] |
2021―Jul―30 |
Fluvoxamine and amantadine: central nervous system acting drugs repositioned for COVID-19 as early intervention |
Konrad Rejdak, Paweł Grieb |
| 13 |
[GO] |
2021―Jun―30 |
The impact of SARS-Cov-2 on the Nervous system and Mental Health |
Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Mikhail Arisov, Julia Fedotova, Lucia Gozzo, Filippo Drago, Weihong Lu, Alexey Sarapultsev, Vadim Tceilikman, Denis Baranenko |
| 14 |
[GO] |
2021―Apr―08 |
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System |
Giselle Pentón-Rol, Javier Marín-Prida, Mark F. McCarty |
| 15 |
[GO] |
2021―Mar―31 |
Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint |
Marika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, Chiara Calderoni, Ferdinando Nicoletti, Ruggero Capra, Marco Salvetti, Diego Centonze |
| 16 |
[GO] |
2021―Mar―16 |
The Stress of the COVID-19 Pandemic: Beyond the Data |
Samina Salim |
| 17 |
[GO] |
2021―Jan―14 |
Crosstalk Between Covid-19 And Associated Neurological Disorders: A Review |
Subham Das, Alex Joseph |
| 18 |
[GO] |
2021―Jan―14 |
PTSD in the COVID-19 Era |
Farah Chamaa, Hisham F. Bahmad, Batoul Darwish, Jana M. Kobeissi, Malak Hoballah, Sibell Bou Nassif, Yara Ghandour, Jean-Paul Saliba, Nada Lawand, Wassim Abou-Kheir |
| 19 |
[GO] |
2020―May―07 |
Emerging evidence for neuropsycho-consequences of COVID-19 |
Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Fang Fang, Xuefei Lv, Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Zhicheng Lin, Nian Xiong |
|
